Cell lines and culture conditions. Human osteosarcoma Sa OS cells (p53-null) were cultured as described previously (12). Saos-2-Tet-hp53 cells (40) were cultured in Tet System Approved FBS (BD Biosciences) and p53 was induced by using 1 µg/ml doxocycline (DOX) (BD Biosciences). U-2 OS cells sensitization to DXR (Adriamycin ® ; Sigma) was assayed following cell exposure to 1 µM of the drug for 24 h. Human ovarian SKOV-3 (p53-null), lung A549 (WT-p53) and breast MCF-7 (WT-p53)
Immunoblotting analysis of cell culture supernatants, antibodies. Culture medium samples were prepared as described previously (22). Samples were adjusted by Bradford (BioRad), mixed with reducing Laemmli buffer and proteins were fractionated by SDS-PAGE followed by immunoblotting (22). Immunoblotting antibodies: α-tubulin (DM1A; Calbiochem), Band 3 (B-9277, Sigma), GRP78
(sc-1050; Santa Cruz biotech), Haemoglobin (Hb) (CR8000GAP, Europa Bioproducts).
Immunofluorescence staining and Confocal Laser Scanning Microscopy (CLSM). ER and Golgi
were immunostained by using the SelectFX™ Alexa Fluor ® 488 ER Labeling Kit (S34200, Invitrogen) and a mouse monoclonal antibody against human Golgin-97 (A-21270, Invitrogen) respectively.
Preparation of RBC membranes and cytosol. Venous blood from healthy volunteers was collected in
EDTA-heparin containing tubes and RBCs were separated by low speed centrifugation (3,000 x g, 10 min). RBC membranes without Hb (white ghosts) were prepared by hypotonic lysis of RBCs in phosphate buffer (41) containing protease inhibitors. The ghosts were collected by high speed centrifugation (17,500 x g, 20 min) and washed thoroughly. The haemolysate collected after the first centrifugation of the ghost preparation was re-centrifuged to remove any contaminating membrane debris; the collected supernatant represents the RBC cytosol. 
